gadolinium dtpa has been researched along with sorbitol in 12 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (sorbitol) | Trials (sorbitol) | Recent Studies (post-2010) (sorbitol) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 6,530 | 359 | 946 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engel, A; Gylys-Morin, V; Haghighi, P; Hajek, PC; Kramer, F; Neumann, CH; Resnick, D; Sartoris, DJ | 1 |
| Kawamura, J; Keyaki, A; Kuroda, Y; Makita, Y; Matsuo, M; Miki, Y; Nishizawa, S | 1 |
| Agnoli, AL; Herrmann, S | 1 |
| Blumenfield, DM; Blumetti, RF; Goldstein, HA; Holyoak, WL; Hugo, FP; Kashanian, FK | 1 |
| Kieffer, SA | 1 |
| Bielke, G; Grigat, M; Higer, HP; Jungke, M; Just, M; Kunze, S; Meindl, S; Pedrosa, P; Voth, D | 1 |
| Bravo, S; Krol, G; Sze, G | 1 |
| Niendorf, HP; Seifert, W | 1 |
| Niendorf, HP | 1 |
| Braffman, BH; Brorson, JR; Goldberg, HI; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH | 1 |
| Atlas, SW; Galetta, S; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH | 1 |
| Araújo, JR; Gonçalves, P; Martel, F; Santos, A | 1 |
3 trial(s) available for gadolinium dtpa and sorbitol
| Article | Year |
|---|---|
Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Topics: Bilirubin; Clinical Trials as Topic; Contrast Media; Drug Combinations; Electrocardiography; Electroencephalography; Gadolinium; Gadolinium DTPA; Headache; Humans; Iron; Magnetic Resonance Imaging; Meglumine; Nausea; Organometallic Compounds; Paresthesia; Pentetic Acid; Research Design; Sorbitol; United States | 1990 |
Gadopentetate dimeglumine: observations on the clinical research process.
Topics: Clinical Trials as Topic; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Research Design; Sorbitol; United States; United States Food and Drug Administration | 1990 |
Serum iron and serum bilirubin after administration of Gd-DTPA-dimeglumine. A pharmacologic study in healthy volunteers.
Topics: Adult; Bilirubin; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Iron; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Random Allocation; Sorbitol | 1988 |
9 other study(ies) available for gadolinium dtpa and sorbitol
| Article | Year |
|---|---|
The effect of intra-articular gadolinium-DTPA on synovial membrane and cartilage.
Topics: Animals; Cartilage, Articular; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Injections, Intra-Articular; Knee Joint; Meglumine; Organometallic Compounds; Pentetic Acid; Rabbits; Sorbitol; Synovial Membrane | 1990 |
Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
Topics: Adenoma; Adult; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Sorbitol | 1990 |
[Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
Topics: Astrocytoma; Brain; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Meglumine; Neoplasm Staging; Oligodendroglioma; Organometallic Compounds; Pentetic Acid; Sorbitol | 1990 |
[Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
Topics: Brain Diseases; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol | 1988 |
Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol; Spinal Cord Diseases; Spinal Cord Neoplasms; Spinal Diseases; Spinal Neoplasms; Time Factors | 1989 |
Gadolinium-DTPA: a new contrast agent.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol | 1988 |
Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Blood-Brain Barrier; Brain; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Time Factors | 1988 |
Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Brain; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Tomography, X-Ray Computed | 1987 |
Intestinal permeability to glucose after experimental traumatic brain injury: effect of gadopentetate dimeglumine administration.
Topics: 3-O-Methylglucose; Animals; Biological Transport; Brain Injuries; Deoxyglucose; Gadolinium DTPA; Glucose; Glucose Transporter Type 2; In Vitro Techniques; Injections, Intravenous; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Permeability; Rats; Rats, Wistar; Sodium-Glucose Transporter 1; Sorbitol | 2008 |